Myfortic (Mycophenolic Acid)

Mycophenolic acid, the active ingredient in Myfortic, is an immunosuppressant presented as an enteric‑coated oral tablet for oral use. It inhibits lymphocyte proliferation and is indicated to prevent rejection of the transplanted kidney, heart, or liver and supports graft survival. The formulation protects the stomach and releases the drug in the intestine.

GNH USA supplies Myfortic as a licensed, GDP‑compliant supplier serving hospitals, transplant centres and pharmacies worldwide, providing regulatory‑approved batches and logistics support for reliable global delivery. Our team coordinates with import authorities to ensure compliance with local regulations.

Myfortic is an immunosuppressive agent used to prevent organ rejection in transplant patients.

- Renal transplantation: helps prevent rejection of the transplanted kidney and supports graft survival. - Heart transplantation: reduces the risk of cardiac graft rejection and maintains heart function. - Liver transplantation: assists in avoiding liver graft rejection and promotes long‑term organ function.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often transient. - Abdominal pain: discomfort or cramping. - Headache: occasional tension‑type headache. - Infections: increased susceptibility to common infections.

Serious or Rare Side Effects: - Leukopenia: significant reduction in white blood cells. - Severe infection: opportunistic or systemic infections. - Hepatotoxicity: abnormal liver enzymes or liver injury. - Malignancy: increased risk of certain cancers with long‑term use.

Patients should be monitored and counseled before and during therapy.

- Monitor blood counts: regular CBC to detect leukopenia or anemia. - Assess renal function: evaluate creatinine and adjust dose if needed. - Avoid live vaccines: increased risk of infection with attenuated organisms. - Pregnancy: discuss potential risks with a healthcare professional before use. - Store at ambient temperature: keep below 25°C, protect from moisture and store in the original packaging.

Myfortic may interact with several medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Cyclosporine: can increase mycophenolic acid exposure, raising toxicity risk. - Tacrolimus: may elevate drug levels, necessitating dose adjustment. - Antacids containing aluminum or magnesium: reduce absorption of mycophenolic acid.

Moderate Interactions (Monitor Closely): - Azathioprine: additive bone‑marrow suppression; monitor blood counts. - Rifampin or other strong inducers: lower mycophenolic acid concentrations. - Live vaccines: increased infection risk; evaluate benefit versus risk.